Navigation Links
Human Genome Sciences Announces Third Quarter 2008 Financial Results and Key Developments
Date:11/6/2008

- Treatment completed in Albuferon(R) Phase 3 trials; first Phase 3 data in

December 2008 - - Enrollment completed in LymphoStat-B(R) Phase 3 trials; first Phase 3

data in mid-2009 -

- HGS updates financial guidance -

ROCKVILLE, Md., Nov. 6 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced financial results and key developments for the quarter ended September 30, 2008.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080416/HGSLOGO )

"Albuferon, LymphoStat-B and our oncology program all continued to make substantial progress during the third quarter. In addition, we entered into an exclusive agreement with Hospira that will enable HGS to generate revenue in the coming years by leveraging our process development and manufacturing capabilities," said H. Thomas Watkins, President and Chief Executive Officer, HGS. "We are on track to report our first Phase 3 data for Albuferon in December 2008. We are on track to report our first Phase 3 data for LymphoStat-B by mid-2009. We have also met every milestone under our contract to supply ABthrax to the U.S. Strategic National Stockpile. We will soon complete production, and we are currently awaiting authorization to begin delivery. However, it now appears that the timing of this authorization is likely to cause the ABthrax sales we previously expected to recognize in 2008, to be recognized instead in 2009. We are updating our 2008 financial guidance accordingly. We continue to believe that ABthrax offers a significant step forward in the treatment of inhalational anthrax and could pla
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Data to Be Presented at 58th Annual Meeting of The American Society of Human Genetics
2. Ambrx to Present Phase I/II Clinical Data for Optimized, Long Acting Human Growth Hormone Analogue
3. Complete Genomics Chooses Isilon IQ to Power Worlds First Complete Human Genome Sequencing Service
4. Human Genome Sciences to Sponsor Conference Call to Discuss Third Quarter 2008 Financial Results
5. Human Pheromone Sciences, Inc. - Shareholder Update
6. The human brain minimizes energy expenditure and integrates gravity in to the action plan
7. EntreMeds ENMD-2076 Demonstrates Tumor Regression in Human Colon Cancer Model
8. Humanitarian Offers $75 Million for Single Dose Sterilization of Cats and Dogs
9. Pioneer(R) Surgical Technology Announces First Human Implants of New nanOss(TM)-Cervical Fusion Device
10. Complete Genomics Launches, Becomes Worlds First Large-Scale Human Genome Sequencing Company
11. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at JMP Securities Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...,, ST.LOUIS,Nov.24/PRNewswire-FirstCall/--Sig...ngattheNASDAQOMXconferenceonTuesday,December1stat1...listenvialiveaudiobroadcastovertheInternetavailabl... .Userscanclickthe"Webcast"icontoaccessthisfile. ...ngLifeScienceandHighTechnologycompany.Itschemicala...
(Date:11/24/2009)...,, SHANGHAI,Nov.24/PRNewswire-Asia/--Shanghai...istration(SFDA)hasapprovedthe,investigationalnewdr...),aninnovativeinsulinformulationtotreatdiabetes.Th...Iclinicalstudy. , Diabetesisadisordercharacte...licationsofdiabetesoftenresultinseveremicro-and,ma...
(Date:11/24/2009)...,, DUBLIN,November24/PRNewswire-FirstCall/--S...ybiopharmaceuticalcompany,today,announcedthatithas...lucerasealfa,thecompany,senzymereplacementtherapyi...Thisisthethirdmarketing,applicationforvelagluceras...intheUnitedStatesandCanada. , Basedonaglobals...
(Date:11/24/2009)... Chemical Abstracts Servi...n, reports that China,s patent office is now the w...ations in chemistry. China trailed Japan,s patent ...on (WIPO), and the United States Patent and Tradem...sed the USPTO in 2005, WIPO in 2006, and exceeded ...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3
...iv University a network of tiny sensors as small ... most determined intruder. Scattered outdoors on ... floor of a bank, the dewdrops are a completely ne...ecuring wide swathes of property. , Prof. Yoram S...neering team drew upon the space-age science of mo...
...ty of their drinking water for granted, that ordin...says Prof. Abraham Katzir of Tel Aviv University,s... threat of contamination due to industrial spillag... developed a new system to monitor the safety of a.... , Modifying special fibers developed in his Te...
...p expertise to strengthen its European business ,...Pharm Pvt. Ltd., a leading multinational full serv...nounced the appointment of Scott L. Spector as Pre...ll be based in the Offenbach, Germany office of O... Mediation more than 15 years of international CRO...
Other Biology Technology:Intruder alert: Tel Aviv University's 'Smart Dew' will find you! 2Monitoring water through a snake's eyes 2Monitoring water through a snake's eyes 3SIRO Group Appoints Scott L. Spector as President, Strategic Operations, for its European Business 2
(Date:11/25/2009)...ead of the Cell Death Research Laboratory in the U...en awarded the prestigious Johnson & Johnson Focus...use of brain cell damage in Parkinson,s disease. T... in support of innovation and excellence in scienc... earlier this month at an event at the Hyatt Regen...
(Date:11/25/2009)...ity assistant professors recently received funding...tinue research beneficial to understanding the env...istopher Blackwood, assistant professor in the Dep... to support two separate research projects. , Hi...ser Communities and Functions from the Leaf to the...
(Date:11/24/2009)...titute (LRI) today named 12 new grant recipients f...ize innovative work across a broad spectrum of lup...y, novelty, and potential to drive scientific disc...omplex disease of systemic lupus. , The 2009 gra...rs across the nation and include interdisciplinary...
Breaking Biology News(10 mins):Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Kent State University professors focus research on the environment with grants totaling $890,000 2Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3HBA Global Announces Finalists for the 2009 International Package Design Awards 28IPDA 29 55290 1HBA Global Announces Finalists for the 2009 International Package Design Awards 28IPDA 29 55290 2HBA Global Announces Finalists for the 2009 International Package Design Awards 28IPDA 29 55290 3CardioDx Completes Validation Study of First Of Its Kind Genomic Test for Coronary Artery Disease 4894 1CardioDx Completes Validation Study of First Of Its Kind Genomic Test for Coronary Artery Disease 4894 2CardioDx Completes Validation Study of First Of Its Kind Genomic Test for Coronary Artery Disease 4894 3CardioDx Completes Validation Study of First Of Its Kind Genomic Test for Coronary Artery Disease 4894 4Adamas Pharmaceuticals Expands Management Team 3B Names Michael D Coffee and Amy K Patick to Executive Positions 55287 1Adamas Pharmaceuticals Expands Management Team 3B Names Michael D Coffee and Amy K Patick to Executive Positions 55287 2Adamas Pharmaceuticals Expands Management Team 3B Names Michael D Coffee and Amy K Patick to Executive Positions 55287 3Adamas Pharmaceuticals Expands Management Team 3B Names Michael D Coffee and Amy K Patick to Executive Positions 55287 4
... the University of Pennsylvania School of Medicine...nfecting bacteria further shuts down a protein tha...sruption to this protein that conveys ions from lu...inside the lung. The finding suggests a new therap...cystic fibrosis (CF) patients. , Lung infection,...
...y be able to be filtered from human blood saving t...first innovation by Queensland University of Techn...specially designed ceramic membranes for nanofiltr...al to remove viruses from water, air and blood. ...hool of Physical and Chemical Sciences, is leading...
...ely touted as an eco-friendly, clean-burning fuel....fuel made primarily from ethanol instead of pure g...and hospitalizations would likely increase, accord...ric scientist Mark Z. Jacobson. His findings are p...rnal Environmental Science & Technology (ES&am...
Other Biology News:Penn study on lung-infecting bacterial enzyme suggests new approach to cystic fibrosis treatment 2QUT scientists on the way to sifting out a cure for HIV 2Ethanol vehicles pose a significant risk to human health, study finds 2Ethanol vehicles pose a significant risk to human health, study finds 3
Cytofix Buffer from BD Biosciences Pharmingen
Rabbit Anti-JAK1, phospho (Tyr1022 / Tyr1023) Polyclonal Antibody, Unconjugated from Abcam
Perm/Wash Buffer from BD Biosciences Pharmingen
PCR purification kit from BioPioneer
Biology Products: